Table 1 Clinical characteristics and aortic valve values in patients with aortic stenosis.
Number | Age in years | Sex | EF (%) | AR grade | MR grade | AV gradient (mmHg) | 2D‐TTE AVA (cm2) | 3D/2D AVA (cm2) | RT3D AVA (cm2) | TEE AVA (cm2) | Cath AVA (cm2) |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 76 | M | 40 | 2 | 2 | 67 | 0.70 | 0.77 | 0.80 | 0.89 | 0.75 |
2 | 60 | M | 30 | 1 | 2 | 48 | 0.90 | 0.90 | 0.90 | 0.76 | 1.25 |
3* | 64 | M | 68 | 1 | 1 | 36 | 0.90 | 0.98 | 0.88 | 0.99 | 0.95 |
4 | 83 | M | 55 | 1 | 1 | 71 | 0.80 | 0.73 | 0.75 | 0.93 | 0.79 |
5* | 65 | M | 65 | 2 | 1 | 105 | 0.69 | 0.65 | 0.78 | 0.87 | 0.77 |
6 | 81 | F | 55 | 1 | 2 | 70 | 0.80 | 0.66 | 0.78 | 0.78 | 0.85 |
7 | 42 | F | 65 | 2 | 2 | 44 | 1.24 | 1.30 | 1.18 | 1.51 | |
8 | 88 | F | 74 | 1 | 1 | 63 | 0.73 | 0.74 | 0.83 | 0.83 | 0.80 |
9* | 38 | F | 38 | 2 | 1 | 41 | 0.70 | 0.74 | 0.64 | 0.80 | |
10 | 55 | M | 67 | 2 | 2 | 64 | 0.80 | 0.89 | 0.81 | 0.96 | |
11 | 70 | M | 28 | 0 | 3 | 56 | 0.75 | 0.70 | 0.63 | 0.72 | |
12 | 91 | M | 58 | 1 | 1 | 21 | 1.23 | 0.99 | 1.05 | 0.79 | 1.00 |
13 | 75 | F | 65 | 0 | 1 | 65 | 0.70 | 0.85 | 0.83 | 0.79 | 0.73 |
14 | 80 | F | 68 | 1 | 3 | 67 | 0.70 | 0.62 | 0.57 | 0.54 | 0.50 |
15 | 85 | M | 28 | 1 | 1 | 38 | 0.60 | 0.64 | 0.67 | 0.65 | 0.63 |
16 | 57 | F | 68 | 0 | 2 | 67 | 0.80 | 0.70 | 0.72 | 0.80 | 0.70 |
17 | 81 | M | 67 | 0 | 0 | 78 | 0.70 | 0.70 | 0.77 | 0.85 | |
18 | 70 | M | 65 | 0 | 2 | 69 | 0.80 | 0.74 | 0.83 | 0.51 | |
19 | 79 | F | 50 | 2 | 2 | 122 | 0.45 | 0.43 | 0.43 | 0.46 | 0.38 |
20 | 78 | M | 60 | 0 | 4 | 71 | 0.57 | 0.62 | 0.56 | 0.74 | |
21 | 67 | M | 68 | 0 | 2 | 90 | 0.82 | 0.87 | 0.80 | 0.88 | |
22 | 81 | M | 20 | 0 | 2 | 22 | 1.95 | 1.87 | 2.00 | 1.97 | |
23 | 75 | M | 65 | 0 | 2 | 22 | 1.95 | 1.92 | 1.87 | 1.98 | |
24 | 72 | F | 68 | 2 | 3 | 20 | 1.57 | 1.87 | 1.63 | 1.91 | 0.66 |
25 | 50 | M | 55 | 1 | 1 | 75 | 0.67 | 0.73 | 0.67 | 0.69 | 0.70 |
26* | 42 | M | 65 | 1 | 1 | 93 | 0.68 | 0.64 | 0.62 | 0.81 | |
27 | 71 | M | 63 | 0 | 1 | 63 | 0.90 | 1.04 | 0.97 | 0.98 | |
28 | 78 | F | 70 | 0 | 0 | 26 | 1.84 | 1.88 | 1.86 | 1.77 | |
29 | 70 | M | 65 | 0 | 0 | 18 | 1.92 | 2.08 | 2.05 | 2.17 | |
30 | 74 | F | 60 | 0 | 3 | 16 | 1.98 | 1.89 | 1.93 | 2.06 | |
31 | 80 | M | 55 | 1 | 1 | 40 | 1.40 | 1.43 | 1.43 | 1.52 | |
32 | 74 | F | 60 | 1 | 2 | 31 | 1.48 | 1.47 | 1.47 | 1.54 | |
33† | 58 | F | 55 | 0 | 1 | 12 | 1.42 | 1.45 | 1.43 | 1.59 |
AR, aortic regurgitation; AVA, aortic valve area; AV gradient, aortic valve peak gradient; Cath, cardiac catheterisation; 3D/2D, 3D‐guided two‐dimensional imaging; EF, ejection fraction; MR, mitral regurgitation; RT3D, volumetric real‐time three‐dimensional echocardiography; TEE, planimetry by transoesophageal echocardiography; 2D‐TTE, Doppler‐derived two‐dimensional transthoracic echocardiography.
*Patients with bicuspid aortic valve.
†Patient with concomitant moderate mitral stenosis.